Search

everythinglearnresearchcommunity

for

Search:↓

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Statins do not help improve alopecia areata.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Alopecia areata is the most common type of baldness treated with corticosteroids and minoxidil.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Pre-sternal keloids are more common in males and can be effectively treated with injections, though recurrences may need more treatment.

PRP combined with vitamin D improves vitiligo more effectively than vitamin D alone.

Cimetidine is not a first-choice treatment for female hair loss, and there's no consistently successful treatment for this condition in men or normal hormone level women.

Dr. Baral observed that applying minoxidil can cause hair to grow in areas other than where it was applied.

Minoxidil caused hair to grow in unintended areas, like a tail, in a young girl.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

PRP therapy is a promising treatment for male hair loss on the vertex.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.